Literature DB >> 7911382

p53 accumulation in polynuclear-giant-cells.

T Wiethege1, B Voss, K M Müller.   

Abstract

Accumulation of p53 has been reported in nearly all malignant human tumours. Macrophage derived giant cells of sarcoid granulomas in human lung tissue also show intense staining for p53 while normal alveolar macrophages remain unstained. Since sarcoid giant cells are not considered to be either pre-neoplastic nor to exhibit p53 gene mutations, two different physiological functions of p53 may be illustrated. Alveolar macrophages were isolated from rat lungs and cultured in vitro. Accumulation of p53 was observed by indirect immunohistochemistry after application of polyclonal rabbit serum directed against murine p53 (CM5). Antiproliferating cell nuclear antigen (PCNA) antibodies were used to study DNA synthesis. Most of the multinucleated giant cells derived from macrophages accumulated p53 in the cytoplasm, while only few nuclei were stained. PCNA was found in most giant cells nuclei. However, PCNA positivity was visible in few mononucleated macrophages. Isolated alveolar macrophages in vitro clearly divide and since nuclear division is a late event in the cell cycle, p53 may be involved in G1/S-control and in other cell-cycle-checkpoints between mitosis and cytokinesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911382     DOI: 10.1007/bf00190556

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  34 in total

1.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

2.  Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations.

Authors:  J K Wu; Z Ye; B T Darras
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

3.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene.

Authors:  A Lavigueur; V Maltby; D Mock; J Rossant; T Pawson; A Bernstein
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 7.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

8.  Localization of elastase and tumor necrosis factor alpha mRNA by non-radioactive in situ hybridization in cultures of alveolar macrophages.

Authors:  T Wiethege; B Voss; T Pohle; A Fisseler-Eckhoff; K M Müller
Journal:  Pathol Res Pract       Date:  1991-09       Impact factor: 3.250

9.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

10.  Comparison between p53 staining in tissue sections and p53 proteins levels measured by an ELISA technique.

Authors:  B Vojtĕsek; C J Fisher; D M Barnes; D P Lane
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  1 in total

1.  Ultrastructure of multinucleated giant cell apoptosis in foreign-body granuloma.

Authors:  T Honma; T Hamasaki
Journal:  Virchows Arch       Date:  1996-06       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.